Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Artikel i vetenskaplig tidskrift, 2008
It is of great significance to find better markers to correctly distinguish between high-risk and low-risk breast cancer patients since the majority of breast cancer cases are at present being overtreated.
Follow-Up Studies
Kaplan-Meier Estimate
genetics
mortality
Biological
Female
Tumor Markers
genetics
Ductal
pathology
Humans
diagnosis
Breast
Gene Expression Profiling
Cluster Analysis
genetics
Predictive Value of Tests
Breast Neoplasms
Oligonucleotide Array Sequence Analysis
pathology
mortality
Lymphatic Metastasis
Carcinoma
diagnosis
Prognosis
Middle Aged
Författare
Elin Karlsson
Göteborgs universitet
Ulla Delle
Göteborgs universitet
Anna Danielsson
Göteborgs universitet
Björn Olsson
Frida Abel
Göteborgs universitet
Per Karlsson
Göteborgs universitet
Khalil Helou
Göteborgs universitet
BMC Cancer
1471-2407 (ISSN)
Vol. 8 254-Ämneskategorier
Medicinska grundvetenskaper
Klinisk medicin
DOI
10.1186/1471-2407-8-254
PubMed
18778486